Detalhe da pesquisa
1.
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes.
Hum Mol Genet
; 32(16): 2646-2655, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369012
2.
Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice.
Int J Mol Sci
; 25(7)2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612527
3.
The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.
Liver Int
; 42(3): 651-662, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050550
4.
OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1.
Cell Mol Life Sci
; 78(23): 7505-7518, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647142
5.
Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma.
Hepatology
; 72(4): 1267-1282, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961955
6.
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials.
Liver Int
; 40(10): 2476-2488, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021346
7.
Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
Semin Liver Dis
; 37(2): 109-118, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28388736
8.
Akt-mediated foxo1 inhibition is required for liver regeneration.
Hepatology
; 63(5): 1660-74, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26473496
9.
The impact of direct antiviral agents on the development and recurrence of hepatocellular carcinoma.
Liver Int
; 37 Suppl 1: 136-139, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052619
10.
Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.
Antimicrob Agents Chemother
; 58(6): 3451-60, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24709263
11.
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma.
Cancers (Basel)
; 16(8)2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672578
12.
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with ß-caryophyllene oxide.
Biomed Pharmacother
; 170: 116038, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141281
13.
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells.
Biomark Res
; 12(1): 38, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594765
14.
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
Gut
; 61(10): 1481-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287594
15.
Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients.
Adv Lab Med
; 4(3): 218-226, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38075169
16.
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis.
Cancers (Basel)
; 14(9)2022 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565178
17.
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
Cells
; 11(17)2022 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36078082
18.
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib.
World J Hepatol
; 14(7): 1438-1458, 2022 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36158918
19.
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity.
Oncotarget
; 12(5): 440-449, 2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33747359
20.
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma.
Cancers (Basel)
; 13(3)2021 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33498698